GXH - Green Cross Health Limited (GXH) CEO Resignation

Following the sale of the Medical division, Group CEO Rachael Newfield has resigned and will leave Green Cross Health on 29 January 2027.

Rachael has led Green Cross Health through a significant period of change. This has included the divestment of both the Community Health and Medical divisions and transforming the company into a pharmacy-focused business. Rachael has led investment in initiatives such as the Health Hubs providing a platform for further service expansion and the opportunity for Pharmacy to have an increasing role in the New Zealand health system. The Board thanks her for her contribution and leadership.

With the Group now fully focused on its pharmacy operations, the Board will look to appoint a General Manager Pharmacy to lead the business through its next phase of growth.

John Bolland

Director

• Green Cross Health Limited (GXH) CEO Resignation

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

CVT - Comvita Limited director nominations
September 4th Morning Report
BRW - Revised offer from Floorscape Limited for 100% of Bremworth
WIN - Winton Appoints Michael Stiassny as Independent Chair
WCO - Offer of new shares to selected investors
GNE - Genesis secures additional gas to strengthen fuel portfolio
FSF - Fonterra provides update on forecast FY26 earnings
September 2nd Morning Report
TWL - Amendments to Notice of Annual Shareholders' Meeting
Devon Funds Morning Note - 01 September 2026